Putnam Investments LLC Moderna, Inc. Transaction History

Putnam Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 22, 2023	SELL	$135.66 - $197.02 $6,376 - $9,259	-47 Reduced 3.32%	1,369 $210,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $167,626 - $297,416	1,416 New	1,416 $254,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $7.21 Million - $10.9 Million	-61,549 Reduced 69.6%	26,884 $3.84 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $9.05 Million - $16.8 Million	-71,562 Reduced 44.73%	88,433 $15.2 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $19.5 Million - $31.9 Million	-86,458 Reduced 35.08%	159,995 $40.6 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $54.7 Million - $119 Million	246,453 New	246,453 $94.8 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $5.06 Million - $8.61 Million	-46,301 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $3.04 Million - $7.86 Million	46,301 New	46,301 $4.84 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.